Hennion & Walsh Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35,740	Closed	-$1.85M	–	822
2022 Q3	$1.85M	Sell	35,740 -1,198	-3%	-$49.5K	0.12%	204
2022 Q2	$915K	Sell	36,938 -30,852	-46%	-$680K	0.06%	333
2022 Q1	$1.7M	Buy	67,790 +11,447	+20%	+$322K	0.09%	246
2021 Q4	$2.05M	Buy	56,343 +17,908	+47%	+$629K	0.1%	228
2021 Q3	$657K	Sell	38,435 -1,903	-5%	-$29.6K	0.03%	450
2021 Q2	$540K	Buy	40,338 +1,510	+4%	+$37.2K	0.03%	508
2021 Q1	$1.99M	Buy	+38,828	New	+$2.34M	0.12%	231

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hennion & Walsh Asset Management's CCXI Position: Q4 2022 in Review

Hennion & Walsh Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 35,740 shares — an estimated $1.85M sold.

Hennion & Walsh Asset Management first reported a position in CCXI in Q1 2021 and held it in 7 quarters. The position peaked at $2.05M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Hennion & Walsh Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 35,740 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.85M.
Hennion & Walsh Asset Management first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 7 quarters.
Hennion & Walsh Asset Management's ChemoCentryx, Inc. position peaked at $2.05M in Q4 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.